Please login to the form below

Not currently logged in
Email:
Password:

pancrelipase

This page shows the latest pancrelipase news and features for those working in and with pharma, biotech and healthcare.

Allergan eyes early 2017 European launch for Enzepi

Allergan eyes early 2017 European launch for Enzepi

CHMP backs the enzyme replacement therapy's approval. Allergan's Enzepi (pancrelipase) has been recommended for European approval to treat exocrine pancreatic insufficiency (EPI) in patients with conditions such as cystic

Latest news

  • AbbVie sales jump on strong Humira gains AbbVie sales jump on strong Humira gains

    Pancreatic enzyme replacement therapy Creon (pancrelipase) grew 20 per cent to $106m while Zemplar (paricalcitol) for hyperparathyroidism was up 12.5 per cent to $63m, reversing first -quarter declines as AbbVie

  • AbbVie expects Humira to drive growth in inaugural guidance AbbVie expects Humira to drive growth in inaugural guidance

    Top of the list in the speciality division is testosterone replacement therapy AndroGel – 31 per cent to $1.15bn in 2012 – with support from Creon (pancrelipase) for pancreatic insufficiency and hypothyroidism

  • Abbott wins FDA approval for infant CF dose

    Abbott has secured approval for an infant-specific dose of CREON (pancrelipase) to treat exocrine pancreatic insufficiency caused by cystic fibrosis (CF). ... Abbott has secured Food and Drug Administration (FDA) approval for an infant-specific dose of

  • Breathing easier

    Canada . Pancrelipase . Zenpep (Eurand)  . Pancreatic disorders . US. Telmisartan/amlodipine. Twynsta (Boehringer Ingelheim).

  • J&J's enzyme treatment approved

    The US Food and Drug Administration (FDA) has announced the approval of Pancreaze (pancrelipase), Johnson &Johnson's (J&J) pancreatic enzyme product (PEP) available as a delayed release capsule. ... This is the third approval for a PEP by the FDA since

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...